Medicibis ("Mendo"), a Canadian licensed producer and owner of Mendo Cannabis, an online portal for medical patients that ships nationwide, announced today it has reached an agreement with NOYA Cannabis Inc. ("NOYA"), to be their exclusive medical distributor in Canada. 

Industry Leading Cannabis Companies Enter Agreement Combining Expertise, Ambitions, and End-to-End Supply Chain Scalability to Expand into New Markets

Final Bell, a provider of end-to-end supply chain solutions for leading cannabis brands, and SHERBINSKIS, the cult favorite California-based cannabis company, have partnered to bring SHERBINSKIS products to new geographies, beginning with Canada. The first highly anticipated product launch, Orange Sherbs Live Resin All-in-One Vape, quickly sold out upon release in Ontario.

A petition supporting automatic expungement for Canadians living with nonviolent cannabis convictions will soon be heard in the House of Commons

The tweet from Justin Bieber’s dad arrived too late.

Just past noon on April 19, a petition initiated by Toronto-based cannabis lawyer Russell Bennett closed with 301 signatures. The petition asked the federal government to redress the harms of 95 years of cannabis prohibition by acknowledging that the plant never should have been criminalized in the first place and grant expungements to Canadian convicted of cannabis offences.

If the petition had gained 500 signatures, the government would have been required to table a response.

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced it has completed its previously announced acquisition of TerraFarma Inc. (parent company of Thrive Cannabis) ("Thrive") (the "Transaction") for aggregate initial consideration of $38 million paid in cash and Aurora common shares ("Aurora Shares"), and up to $30 million in potential earnout amounts, payable in cash, Aurora Shares or a combination of both (at the election of Aurora), subject to Thrive achieving certain revenue targets within two years of closing of the Transaction.

Three years into the federal legalization of cannabis in Canada, almost all the pieces are in place for the growth of a robust cannabis tourism industry — except one.

Cannabis tourism includes the variety of activities, events and places that are part of any vacation or travel plans that incorporate cannabis. What’s missing are the rules around consuming cannabis socially in public settings, highlighting a broader issue about cannabis legalization in Canada.

My recent research on the cannabis industry suggests that integrating cannabis consumption into tourism will have positive social impacts toward normalization, acceptance and tolerance of cannabis.

More than half of Canadians with multiple sclerosis (MS) report using cannabis to help manage their symptoms, according to a new study.

The study, “Medical cannabis use in Canadians with multiple sclerosis,” was published in Multiple Sclerosis and Related Disorders.

Humans have used the cannabis plant for millennia, both as a recreational intoxicant and as a medicine. Although its potential benefits for MS remain unproven, emerging research suggests it can help reduce spasticity, improve sleep, and ease pain.

Medical cannabis use was legalized in Canada in 2001. Recreational use was legalized nationwide nearly two decades later in 2018.

Cannabis has become increasingly common since a Canadian Senate committee first recommended legalizing the substance in 2002. They argued that prohibiting it didn’t reduce the use of cannabis products and that legalization was a better move.

The goals of legalization were “to keep profits out of the pockets of criminals” and “to protect public health and safety by allowing adults access to legal cannabis.” In October 2018, the first sales of legal, adult-use cannabis — including CBD, or cannabidiol, products — occurred.

Our research investigates how businesses strategize in the emerging cannabis industry that is still in its early stages of formation.

Earnings season has started to kick into high gear after the world’s largest technology companies reported quarterly financial results and the trend so far has not been pretty. 

 Greenway Greenhouse Cannabis Corporation (CSE: GWAY) ("Greenway Greenhouse" or the "Company") is pleased to announce that  Warrants arising from a private placement that was announced on November 23rd, 2021 (the "Offering") begin trading today on the Canadian Securities Exchange ("CSE") under the name "GWAY.WT"